FDA Succession Planning Targeted In House Legislation
Executive Summary
Hamburg’s departure from commissioner post seems to be proceeding smoothly; proposals in 21st Century Cures bill would mandate a similar process always be followed.
You may also be interested in...
Califf Nomination Adds New Dynamic, Maybe New Provisions, To FDA Reform Bills
Senate legislation may be influenced by movement to push through Califf’s nomination for FDA commissioner.
Putting Patients In Charge Of Drug Development. Like CEO In Charge
FDA, PhRMA and BIO leadership could look considerably different under a modest proposal from National Health Council's Marc Boutin.
House Trims 21st Century Cures Fat: Draft Bill Loses Half Its Weight
New discussion draft drops controversial exclusivity extensions and some other lesser-known ideas that may have benefited FDA and sponsors, but some placeholders still need to be filled.